ArticleFrontiers in endocrinology2019

It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth.

Megan M Oberle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.